ALLERGY AND ASTHMA CLINICS LIMITED
Opportunity 76/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-10-31 | 2023-10-31 |
|---|---|---|
| Average employees | 4 | 500 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (26 events)Click to expand
- 2025-07-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-07-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-11-29📄termination-director-company-with-name-termination-dateofficers · TM01
- 2023-11-29📄capital-allotment-sharescapital · SH01
- 2023-10-27➖NASSER, Safiyah Hanifah resigneddirector
- 2023-07-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-08-31➖NASSER, Syed Muhammad Hashim resigneddirector
- 2022-08-31📄termination-director-company-with-name-termination-dateofficers · TM01
- 2022-07-28📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-07-28📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-10-28📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2020-10-28📄capital-allotment-sharescapital · SH01
- 2020-08-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-05-11➕NASSER, Nafisah Saidah Noor appointeddirector
- 2020-05-11📄appoint-person-director-company-with-name-dateofficers · AP01
- 2018-12-17➕NASSER, Jane Karen, Dr appointeddirector
- 2018-12-17➕NASSER, Syed Muhammad Hanif appointeddirector
- 2018-12-17➕NASSER, Safiyah Hanifah appointeddirector
- 2018-12-17➕NASSER, Syed Muhammad Hashim appointeddirector
- 2018-12-17📄capital-allotment-sharescapital · SH01
- 2018-12-17📄change-person-director-company-with-change-dateofficers · CH01
- 2018-12-17📄appoint-person-director-company-with-name-dateofficers · AP01
- 2018-12-17📄appoint-person-director-company-with-name-dateofficers · AP01
- 2018-12-17📄appoint-person-director-company-with-name-dateofficers · AP01
- 2018-10-11🏢Company incorporatedAs ALLERGY AND ASTHMA CLINICS LIMITED
- 2018-10-11➕NASSER, Syed Muhammad Shuaib appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- -4 active directors: Broader management team in place — suggests transferable governance.
- +Senior director age: Director aged approximately 64 — approaching natural succession window.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Syed Muhammad Shuaib Nasser Individual · British · DOB 03/1962 · age 64 | 50–75% | — | board control50-75% shares · board control | 11/10/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · W postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AGE UK KENSINGTON AND CHELSEA→ 03926026 · est 2000 · no financials extracted | — | — | — | — | 26y | — | — |
| AIBO PLATFORM LTD→ 15931224 · est 2024 | — | — | £1.3k | — | 1y | — | — |
| ALEXANDER HEALTHCARE SERVICES LTD→ 11661039 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ALINEA CLINIC LIMITED→ 16385584 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ALISON EDWARDS LIMITED→ 09808072 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| ALISON GOODWIN LIMITED→ 08318757 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| ALJ AESTHETIC CLINIC LTD→ 17129717 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ALL ABOUT YOU COUNSELLING AND PSYCHOTHERAPY LTD→ 12186649 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ALL CARE (GB) LIMITED→ 05100341 · est 2004 · no financials extracted | — | — | — | — | 22y | — | — |
| ALL EYE NEED LTD→ 08017389 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
| ALLERGOLOGY AND GP CLINIC DR TOMASZ GRZELEWSKI LIMITED→ 14575931 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ALLIED CARE SUPPORT LIMITED→ 16987377 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (4 active · 2 resigned)
Click a director name to see their full track record across all companies.